Acute pain after total knee arthroplasty: 2-arachidonoylglycerol tone and endocannabinoid/eicosanoid crosstalk
Data files
Aug 26, 2025 version files 19.36 KB
-
Endocannabinoids_data_repository.xlsx
17.52 KB
-
README.md
1.84 KB
Abstract
Background: Total knee arthroplasty (TKA) is a surgical procedure that induces intense acute postoperative pain, but the mechanisms that amplify post-TKA pain remain incompletely understood. Endocannabinoids, such as 2-arachidonoylglycerol (2-AG), are endogenous lipids that can produce antinociceptive effects. However, hydrolysis of 2-AG by monoacylglycerol lipase (MAGL) generates arachidonic acid, the precursor to a host of eicosanoids that enhance pain. The presence of this metabolic pathway suggests that individuals with elevated 2-AG levels may be primed to develop greater postoperative pain.
Methods: The primary goal of this prospective study was to determine if intraoperative 2-AG levels in the synovial fluid (SF) and cerebrospinal fluid (CSF) of TKA patients are associated with the magnitude of acute postoperative pain at rest and with ambulation. The secondary goal was to determine whether 2-AG metabolism contributes to prostaglandin E2 (PGE2) biosynthesis in synovial tissue ex vivo.
Results: Ninety subjects were enrolled in the study. SF 2-AG was positively correlated with pain at rest (r = 0.2644; p = 0.0157) and with ambulation (r = 0.3856; p = 0.0005) while CSF 2-AG was associated with pain at rest (r = 0.3312; p = 0.0017) but not with ambulation (r = 0.1454; p 0.1871). Stratification of the results by gender revealed positive correlations between 2-AG and pain in females, which were markedly weaker or not observed in males. Ex vivo analysis demonstrated co-expression of MAGL and cyclooxygenase-2 in synovial membranes, with MAGL inhibition by MJN110 elevating 2-AG levels (median, vehicle: 0.165 nmol/g vs MJN110: 0.325 nmol/g, p = 0.0269) and concomitantly reducing PGE2 (median, vehicle: 5.645 nmol/g vs MJN110: 3.440 nmol/g, p = 0.0425).
Conclusions: Our findings demonstrate that patients presenting with an elevated 2-AG tone develop greater postoperative pain and position MAGL as an enzymatic node linking 2-AG metabolism with eicosanoid biosynthesis in perioperative human tissue.
Dataset DOI: 10.5061/dryad.tmpg4f584
Description of the data and file structure
Intraoperative 2-AG levels in synovial fluid and cerebrospinal fluid of patients undergoing total knee arthroplasty.
Preoperative and postoperative patient-reported pain.
Prostaglandin E2 (PGE2) levels in the synovial fluid of patients undergoing total knee arthroplasty.
2-arachidonoylglycerol (2-AG), arachidonic acid (AA), and PGE2 levels in synovial explants treated with vehicle or 10 uM MJN110.
Files and variables
File: Endocannabinoids_data_repository.xlsx
Tab: Data
Description: Preoperative pain, postoperative pain, and intraoperative 2-AG levels in synovial fluid and cerebrospinal fluid of patients undergoing total knee arthroplasty (TKA).
Variables
- Sex
- Age
- Body mass index (BMI)
- Koos Jr interval pain scores
- Numeric rating scale (NRS) preoperative pain scores
- NRS postoperative pain at rest 24 hours after TKA
- NRS postoperative pain with ambulation 24 hours after TKA
- Morphine equivalent (MME) postoperative analgesia
- Cerebrospinal fluid (CSF) 2-AG levels
- Synovial fluid (SF) 2-AG levels
- SF prostaglandin E2 (PGE2) levels
Tab: Ex vivo
Description: Ex-vivo levels of 2-AG, AA, and PGE2 in synovial tissues incubated with vehicle or the monoacylglycerol lipase (MAGL) inhibitor MJN110 (10 µM) for 6 hours.
Variables
- PGE2 (nmol/g)
- AA (nmol/g)
- 2-AG (nmol/g)
- Vehicle
- 10 µM MJN110
n/a = data not available
Human subjects data
Explicit consent was provided from participants to publish the de-identified data in the public domain. Subjects were de-identified and were assigned a study number representing their data.
